Journal of Isfahan Medical School

Journal of Isfahan Medical School

Predictive Effect of Antimullerian Hormone (AMH) and Number of Antral Follicles (AFC) in Treatment Response to Ovarian Drilling in Clomiphene-Resistant Polycystic Ovary (PCO) Patients

Document Type : Original Article (s)

Authors
Elham Naghshineh 1
Azita Panji 2
Safoura Rouholamin 3
1 Department of Obstetrics & Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 Resident, Department of Obstetrics & Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3 Professor, Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
10.48305/jims.v44.i853.262
Abstract
Background: Ovarian drilling is an effective treatment method for clomiphene-resistant polycystic ovary (PCO) patients. Here we aimed to determine the predictive effects of antimullerian hormone (AMH) and number of antral follicles (AFC) in treatment response.
Methods: This is a clinical trial that was performed in 2021-2022 on 70 patients with PCOS. Eligible patients included based on the mentioned criteria. Demographic data of patients were collected at the beginning of the study. Serum levels of testosterone, follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin, AMH and AFC in these patients were then measured. Patients then underwent ovarian catheterization via laparoscopic technique. The success of ovarian catheterization (the occurrence of ovulation) was defined as the return of regular menstrual cycles over the next year.
Results: patients with response to treatments had significantly higher AMH (P= 0.001) levels. AMH had significant direct relationship with treatment response (r= 1.226, P= 0.004). Patients with AMH higher than 8 had 8.32 times higher chance for response to treatments (P< 0.001).
Conclusion: AMH had significant predictive values in treatment responses. Patients with AMH higher than 8 had 8.32 times higher chance for response to treatments

Highlights

Elham Naghshineh: Google Scholar

Safoura Rouholamin: Google Scholar

Keywords
PCOS
Clomiphene
Ovarian drilling
Antimullerian hormone
Subjects
1.     Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers 2016; 2: 16057.
2.     McCartney CR, Marshall JC. CLINICAL PRACTICE. Polycystic Ovary Syndrome. N Engl J Med 2016; 375(1): 54-64.
3.     Azziz R. Polycystic ovary syndrome. Obstet Gynecol 2018; 132(2): 321-36.
4.     Meier RK. Polycystic Ovary Syndrome. Nurs Clin North Am 2018; 53(3): 407-420.
5.     Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 2018; 14(5): 270-84.
6.     Williams T, Mortada R, Porter S. Diagnosis and treatment of polycystic ovary syndrome. Am Fam Physician 2016; 94(2): 106-13.
7.     Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 2016; 106(1): 6-15.
8.     Bellver J, Rodríguez-Tabernero L, Robles A, Muñoz E, Martínez F, Landeras J, Acevedo B, et al. Polycystic ovary syndrome throughout a woman's life. J Assist Reprod Genet 2018; 35(1): 25-39.
9.     Brown J, Farquhar C. Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome. Cochrane Database Syst Rev 2016; 12(12): CD002249.
10.  Takasaki A, Tamura I, Okada-Hayashi M, Orita T, Tanabe M, Maruyama S, et al. Usefulness of intermittent clomiphene citrate treatment for women with polycystic ovarian syndrome that is resistant to standard clomiphene citrate treatment. Reprod Med Biol 2018; 17(4): 454-8.
11.  Garg D, Tal R. The role of AMH in the pathophysiology of polycystic ovarian syndrome. Reprod Biomed Online 2016; 33(1): 15-28.
12.  Gülşen MS, Ulu İ, Yıldırım Köpük Ş, Kıran G. The role of anti-Müllerian hormone in predicting clomiphene citrate resistance in women with polycystic ovarian syndrome. Gynecol Endocrinol 2019; 35(1): 86-9.
13.  Paramu S. Impact of laparoscopic ovarian drilling on serum anti-mullerian hormone levels in patients with anovulatory Polycystic Ovarian syndrome. Turk J Obstet Gynecol 2016; 13(4): 203-7.
14.  Ellakwa HE, Sanad ZF, Hamza HA, Emara MA, Elsayed MA. Predictors of patient responses to ovulation induction with clomiphene citrate in patients with polycystic ovary syndrome experiencing infertility. Int J Gynaecol Obstet 2016; 133(1): 59-63.
15.  Zehravi M, Maqbool M, Ara I. Polycystic ovary syndrome and infertility: an update. Int J Adolesc Med Health 2021; 34(2): 1-9.
16.  Shi S, Hong T, Jiang F, Zhuang Y, Chen L, Huang X. Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. Medicine (Baltimore) 2020; 99(4): e18383.
17.  Hager M, Wenzl R, Riesenhuber S, Marschalek J, Kuessel L, Mayrhofer D, et al. The prevalence of incidental endometriosis in women undergoing laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome: a retrospective cohort study and meta-analysis. J Clin Med 2019; 8(8): 1210.
18.  Bordewijk EM, Ng KYB, Rakic L, Mol BWJ, Brown J, Crawford TJ, van Wely M. Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev 2020; 2(2): CD001122.
19.  Lebbi I, Ben Temime R, Fadhlaoui A, Feki A. Ovarian Drilling in PCOS: Is it Really Useful? Front Surg 2015; 2: 30.
20.  Mitra S, Nayak PK, Agrawal S. Laparoscopic ovarian drilling: An alternative but not the ultimate in the management of polycystic ovary syndrome. J Nat Sci Biol Med 2015; 6(1): 40-8.
21.  Zakherah M. Ovarian reserve after fixed versus adjusted laparoscopic ovarian drilling in clomiphene resistant PCOS patients. Fertility and Sterility 2014; 102(3): e144-e5.
22.  Majumdar A, Mishra P. Series of 18 Cases of Clomiphene Resistant Anovulatory Women with Polycystic Ovary Syndrome and Altered Response to FSH Stimulation. JFIV Reprod Med Genet 2016; 4(4): 1-2.
23.  Omokanye L, Olatinwo A, Durowade K, Panti A, Salaudeen A, Adewara E. A review of pregnancy outcomes following laparoscopic ovarian drilling for infertile women with clomiphene resistant polycystic ovarian syndrome (PCOS) at a public health facility in Ilorin, Nigeria. Trop J Obstet Gynaecol 2014; 31(2): 74-81.
24.  Rezk M, Emarh M, Alhalaby A. Anti-Müllerian hormone and luteinizing hormone for prediction of spontaneous ovulation after laparoscopic ovarian drilling in clomiphene-resistant polycystic ovary syndrome. Middle East Fertility Society Journal 2016; 21(2): 91-95.
 
Journal of Isfahan Medical School
Volume 44, Issue 853
1st Week, May
May and June 2026
Pages 262-268

  • Receive Date 11 November 2024
  • Accept Date 17 May 2026